Leap Therapeutics Inc. buy BiotechBee
Start price
07.01.24
/
50%
€3.70
Target price
30.09.25
€5.00
Performance (%)
-27.03%
End price
14.12.24
€2.70
Summary
This prediction ended on 14.12.24 with a price of €2.70. The price of Leap Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.03%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Leap Therapeutics Inc. | -17.460% | -17.460% | 11.588% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% |
According to BiotechBee what are the pros and cons of Leap Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year